Navigation Links
Patients at high risk of recurrences of heart disease: Breakthrough in prevention
Date:5/20/2010

This press release is available in French.

Montreal, May 20, 2010 The results of a major clinical study carried out at the Montreal Heart Institute (MHI) by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit de Montral.

The promising findings of this study on VIA-2291 a medication developed by Via Pharmaceuticals, a San Francisco-based biotechnology firm relate to its capacity to effectively reduce inflammation, which can contribute to the formation and progression of atherosclerosis plaque and infarct.

"Up to now, standard treatments for patients with acute coronary syndrome (unstable angina and infarct) have not specifically reduced inflammation, an important component of atherosclerosis. However, research in recent years has allowed us to determine that the presence of inflammation significantly increases the risk of recurrence among these patients. The clinical study was conducted with about 200 patients, and the findings we're publishing show that VIA-2291 may finally offer the solution we need to target and reduce inflammation. In fact, these newly published data strongly support the evaluation of VIA-2291 in larger outcome trials," said Dr. Tardif.

The Montreal Heart Institute's Research Centre directed the study in several hospitals in Canada and the United States as well as analyzed all of the data, including data collected by CAT scans of coronary arteries.

"The publication of this new study attests once again to the excellence of the entire team at the Montreal Heart Institute's Research Centre. While we're clearly satisfied with the findings obtained with VIA-2291, we're even more thrilled at the prospect of taking a big step toward more effective and personalized prevention of cardiovascular disease," concluded Dr. Tardif.


'/>"/>

Contact: Rachel Ladouceur-Girard
rachel.ladouceur-girard@icm-mhi.org
514-376-3330, x 2641
University of Montreal
Source:Eurekalert

Related medicine news :

1. When Heart Patients Discharge Themselves, Hospital Bills Increase
2. A useful tool to detect in vivo angiogenesis in IBD patients: Narrow-band imaging
3. Older patients offer insight into the future of cystic fibrosis
4. Depressed chronic kidney disease patients more likely to face complications
5. First study examines postpolypectomy bleeding in colonoscopy patients on uninterrupted clopidogrel
6. POP ROCK BAND Honor Society Drummer Advocates for Inflammatory Bowel Disease Patients on Capitol Hill in Conjunction with World IBD Day
7. Older Patients More Apt to Be Happy With Plastic Surgery
8. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
9. What Doctors Won't Tell Their Patients About Cancer
10. Well-tolerated radiotherapy provides longer life to patients with recurrent brain cancer
11. Challenging the use of routine repeated chest X-rays in certain patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... Brenton Engineering , powered by Pro ... wrapped products at WestPack 2015, February 9-11, in Anaheim, California. This new solution ... or fully-automatic case packing with a small footprint, rugged, highly flexible, and cost-effective ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... community enrichment program serving the greater Venice, FL area, has initiated a fundraiser ... in a car accident just four days after Christmas. To support this beautiful ...
(Date:2/8/2016)... ... February 08, 2016 , ... FileHold's document management software has ... a cloud hosted environment for FileHold software that is pay per user subscription-based ... applications using the FileHold web services API. DocuSyst also advises clients on fully ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua ... on how healthcare companies can use newly released government data on populations and ... population and intervene and capture the value they create to succeed in new ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women's Excellence staff, in all four ... National Wear Red Day is the first Friday each February and a day ... cause 1 in 3 deaths among women each year – more than all cancers ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Avista Pharma Solutions ("Avista Pharma") announced today ... Financial Officer (CFO). Mr. Setzer is a finance and ... various roles within growing technology and life science companies. ... Executive Director of Finance at INC Research, a publicly ... . Previously, Mr. Setzer served as CFO of ...
(Date:2/8/2016)... 2016 Vestagen Technical Textiles, Inc., a medical ... healthcare and other demanding applications, today announced it has ... replaces Dale Pfost , PhD, who was serving ... also joining Vestagen,s Board of Directors. ® ... barrier technologies that combines fluid repellent, antimicrobial and breathability ...
(Date:2/8/2016)... , Feb. 8, 2016  Astellas Pharma Inc. President ... the promotion of James Robinson as president, Americas ... operations in North and South America , ... Pharma US, representing the commercial organization in the ... 2013. Masao Yoshida , who is retiring ...
Breaking Medicine Technology: